The burgeoning popularity of semaglutide , initially for blood sugar control , is creating significant attention within the UK , prompting a notable shift in medication trends. Access these treatments remains a complex challenge , with National Health Service approval currently limited and specialist practices offering therapy at a higher cost . Co